|
1
|
Yeo SG, Kim DY, Kim TH, Chang HJ, Oh JH,
Park W, Choi DH, Nam H, Kim JS, Cho MJ, Kim JH, Park JH, Kang MK,
Koom WS, Kim JS, Nam TK, Chie EK, Kim JS and Lee KJ: Pathologic
complete response of primary tumor following preoperative
chemoradiotherapy for locally advanced rectal cancer: long-term
outcomes and prognostic significance of pathologic nodal status
(KROG 09-01). Ann Surg. 252:998–1004. 2010. View Article : Google Scholar
|
|
2
|
Kosinski L, Habr-Gama A, Ludwig K and
Perez R: Shifting concepts in rectal cancer management: a review of
contemporary primary rectal cancer treatment strategies. CA Cancer
J Clin. 62:173–202. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Habr-Gama A, Perez RO, Nadalin W, Sabbaga
J, Ribeiro U Jr, Silva e Sousa AH Jr, Campos FG, Kiss DR and
Gama-Rodrigues J: Operative versus nonoperative treatment for stage
0 distal rectal cancer following chemoradiation therapy: long-term
results. Ann Surg. 240:711–718. 2004.PubMed/NCBI
|
|
4
|
Maas M, Beets-Tan RG, Lambregts DM,
Lammering G, Nelemans PJ, Engelen SM, van Dam RM, Jansen RL, Sosef
M, Leijtens JW, Hulsewe KW, Buijsen J and Beets GL: Wait-and-see
policy for clinical complete responders after chemoradiation for
rectal cancer. J Clin Oncol. 29:4633–4640. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Glynne-Jones R and Hughes R: Critical
appraisal of the ‘wait and see’ approach in rectal cancer for
clinical complete responders after chemoradiation. Br J Surg.
99:897–909. 2012.
|
|
6
|
Habr-Gama A, Perez RO, São Julião GP,
Proscurshim I and Gama-Rodrigues J: Nonoperative approaches to
rectal cancer: a critical evaluation. Semin Radiat Oncol.
21:234–239. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Habr-Gama A, Perez RO, Proscurshim I,
Campos FG, Nadalin W, Kiss D and Gama-Rodrigues J: Patterns of
failure and survival for nonoperative treatment of stage c0 distal
rectal cancer following neoadjuvant chemoradiation therapy. J
Gastrointest Surg. 10:1319–1329. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Merkel S, Mansmann U, Hohenberger W and
Hermanek P: Time to locoregional recurrence after curative
resection of rectal carcinoma is prolonged after neoadjuvant
treatment: a systematic review and meta-analysis. Colorectal Dis.
13:123–131. 2011. View Article : Google Scholar
|
|
9
|
Lambregts DM, Vandecaveye V, Barbaro B,
Bakers FC, Lambrecht M, Maas M, Haustermans K, Valentini V, Beets
GL and Beets-Tan RG: Diffusion-weighted MRI for selection of
complete responders after chemoradiation for locally advanced
rectal cancer: a multicenter study. Ann Surg Oncol. 18:2224–2231.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Garcia-Aguilar J, Shi Q, Thomas CR Jr,
Chan E, Cataldo P, Marcet J, Medich D, Pigazzi A, Oommen S and
Posner M; ACOSOG. Pathologic complete response (pCR) to neoadjuvant
chemoradiation (CRT) of uT2uN0 rectal cancer (RC) treated by local
excision (LE): Results of the ACOSOG Z6041 trial. J Clin Oncol.
28(Suppl; abstr 3510): 15s2010.
|
|
11
|
Habr-Gama A, Perez RO, Wynn G, Marks J,
Kessler H and Gama-Rodrigues J: Complete clinical response after
neoadjuvant chemoradiation therapy for distal rectal cancer:
characterization of clinical and endoscopic findings for
standardization. Dis Colon Rectum. 53:1692–1698. 2010. View Article : Google Scholar
|
|
12
|
Habr-Gama A, Perez RO, Proscurshim I,
Nunes Dos Santos RM, Kiss D, Gama-Rodrigues J and Cecconello I:
Interval between surgery and neoadjuvant chemoradiation therapy for
distal rectal cancer: does delayed surgery have an impact on
outcome? Int J Radiat Oncol Biol Phys. 71:1181–1188. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yeo SG, Kim DY, Park JW, Oh JH, Kim SY,
Chang HJ, Kim TH, Kim BC, Sohn DK and Kim MJ: Tumor volume
reduction rate after preoperative chemoradiotherapy as a prognostic
factor in locally advanced rectal cancer. Int J Radiat Oncol Biol
Phys. 82:e193–e199. 2012.PubMed/NCBI
|
|
14
|
Yu SK, Brown G, Heald RJ, Chua S, Cook G,
Barbachano Y, Chau I, Wotherspoon A and Tait DM: Deferral of rectal
surgery following a continued response to preoperative
chemoradiotherapy (Watch and Wait) study: A phase II multicenter
study in the United Kingdom. J Clin Oncol. 29(suppl 4; abstr
489)2011.
|
